XML 80 R3.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Deferred financing costs $ 24,500 $ 17,600
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 50,000,000 50,000,000
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 450,000,000 450,000,000
Common stock, shares issued (in shares) 153,537,296 133,853,565
Common stock, shares outstanding (in shares) 153,537,296 133,853,565
Series B Preferred Stock    
Preferred stock, shares issued (in shares) 6,770,393 6,770,393
Preferred stock, shares outstanding (in shares) 6,770,393 6,770,393
Preferred stock, liquidation preference $ 169,260 $ 169,260
Series C Preferred Stock    
Preferred stock, shares issued (in shares) 0 6,900,000
Preferred stock, shares outstanding (in shares) 0 6,900,000
Preferred stock, liquidation preference $ 0 $ 172,500
Commercial Mortgage Portfolio Segment    
Loans pledged as collateral 4,852,087 3,197,900
Secured Debt    
Deferred financing costs 7,277 0
Line of Credit    
Deferred financing costs 17,190 17,555
Deferred financing costs $ 17,190 $ 17,555